(Q35093640)

6 August 2017

1 reference

title

Modulating T cell responses for the treatment of psoriasis: a focus on efalizumab (English)

1 reference

6 August 2017

Jennifer Clay Cather

1

1 reference

6 August 2017

J Christian Cather

series ordinal

2

1 reference

6 August 2017

Alan Menter

series ordinal

3

1 reference

6 August 2017

language of work or name

English

0 references

publication date

1 April 2003

1 reference

Expert Opinion on Biological Therapy

6 August 2017

published in

1 reference

6 August 2017

volume

3

1 reference

6 August 2017

issue

2

1 reference

6 August 2017

page(s)

361-370

1 reference

Two considerations for patients with psoriasis and their clinicians: what defines mild, moderate, and severe psoriasis? What constitutes a clinically significant improvement when treating psoriasis?

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

Population-based epidemiologic study of psoriasis with emphasis on quality of life assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

Remission of psoriatic lesions with muromonab-CD3 (orthoclone OKT3) treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

Severe combined immunodeficiency mouse-human skin chimeras: a unique animal model for the study of psoriasis and cutaneous inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

Novel immune-based therapies for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

Biologic therapy for psoriasis: the new therapeutic frontier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

Role of lymphocyte adhesion receptors in transient interactions and cell locomotion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

Supergene families meet in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

The lymphocyte function-associated LFA-1, CD2, and LFA-3 molecules: cell adhesion receptors of the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

The immunologic basis for the treatment of psoriasis with new biologic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

The immunological synapse: a molecular machine controlling T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.3.2.361

21 January 2018

Identifiers

DOI

10.1517/14712598.3.2.361

1 reference

6 August 2017

1 reference